|

SPN-821 2400 mg Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Supernus Pharmaceuticals, Inc.1

Indications

  • Major Depressive Disorder (MDD)1
  • Depression1

Garden Grove, California1 trial

Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

Collaborative Neuroscience Network

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.